McGann Michael J. 4
4 · Xylem Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Xylem (XYL) EVP Michael McGann Receives Awards; Shares Withheld
What Happened
- Michael J. McGann, EVP & President, MCS of Xylem Inc. (XYL), reported multiple awards and vestings on March 1–2, 2026. The filing shows vested performance-based shares and an award of derivatives/RSUs: total reported acquisitions equal 12,529 shares (valued at about $1.41M using $128.98/share). Separately, 2,796 shares were withheld/disposed to cover tax liabilities (totaling about $360,629).
- Specific items in the filing include vesting of performance stock units (PSUs) and ESG PSUs (1,966; 1,622; 1,103; 489 shares at $128.98 each), an RSU award (1,610 shares at $0 value on grant), and a derivative award of 5,739 units valued at $128.98 each ($740,216). Withholdings to cover taxes were 2,073; 213; and 510 shares (each valued at $128.98).
Key Details
- Transaction dates and prices:
- 2026-03-01: Vesting/awards — 1,966 @ $128.98 ($253,575); 1,622 @ $128.98 ($209,206); 1,103 @ $128.98 ($142,265); 489 @ $128.98 ($63,071); 5,739 derivative units @ $128.98 ($740,216).
- 2026-03-02: Award of 1,610 RSUs at $0.00 (scheduled to vest in future); withholding to pay taxes — 2,073 @ $128.98 ($267,376); 213 @ $128.98 ($27,473); 510 @ $128.98 ($65,780).
- Aggregate reported: ~12,529 shares acquired (including derivative award), $1.41M total value (using $128.98/share); 2,796 shares withheld ($360,629). Net increase ~9,733 shares.
- Shares owned after the transaction: not disclosed in the filing.
- Notable footnotes:
- Vestings reflect achievement of performance criteria (TSR, Adjusted EBITDA, Revenue, ESG) for grants made in 2021 and 2023.
- The 5,739-unit award is a non‑qualified stock option/derivative scheduled to vest in thirds (Mar 1 of 2027–2029).
- Withheld shares (code F) were used to satisfy tax obligations on vesting.
- Filing timeliness: Form 4 was filed March 3, 2026 (transactions dated Mar 1–2); this appears within the standard two-business-day reporting window.
Context
- These transactions are primarily award vestings and new grants (A = Award/Grant). The withholding (F) entries are routine tax-withholding actions tied to vesting, not open‑market sales. The derivative award is a grant of options/units that vest over future years (not an immediate sale or cash exercise). Such awards are compensation-related and do not by themselves signal immediate insider buying/selling intent.
Insider Transaction Report
Form 4
Xylem Inc.XYL
McGann Michael J.
EVP & President, MCS
Transactions
- Award
Common Stock
[F1][F2]2026-03-01$128.98/sh+1,966$253,575→ 10,197 total - Award
Common Stock
[F3]2026-03-01$128.98/sh+1,622$209,206→ 11,819 total - Award
Common Stock
[F4]2026-03-01$128.98/sh+1,103$142,265→ 12,922 total - Award
Common Stock
[F5]2026-03-01$128.98/sh+489$63,071→ 13,411 total - Award
Common Stock
[F6]2026-03-02+1,610→ 15,021 total - Tax Payment
Common Stock
[F7]2026-03-02$128.98/sh−2,073$267,376→ 12,948 total - Tax Payment
Common Stock
[F8]2026-03-02$128.98/sh−213$27,473→ 12,735 total - Tax Payment
Common Stock
[F9]2026-03-02$128.98/sh−510$65,780→ 12,225 total - Award
Non-Qualified Stock Options (Right to Buy)
[F10]2026-03-02$128.98/sh+5,739$740,216→ 5,739 totalExercise: $128.98Exp: 2036-03-02→ Common Stock (5,739 underlying)
Footnotes (10)
- [F1]Reflects the acquisition of 1,966 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
- [F10]Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
- [F2]Includes additional shares due to dividend reinvestment.
- [F3]Reflects the acquisition of 1,622 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
- [F4]Reflects the acquisition of 1,103 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
- [F5]Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
- [F6]Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
- [F7]Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
- [F8]Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
- [F9]Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (269) and March 1, 2024 (241) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Signature
/s/ Mike Nazario, by power of attorney for Michael J. McGann|2026-03-03